(PRWEB UK) 16 December 2012
The Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast states that the worldwide pediatrics vaccine market is expected to reach over US$ 23 Billion by 2015. This incremental growth has been due to blockbuster vaccines such as Prevnar7, Prevnar 13, Rotarix and Rotateq.
It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations and boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011.
In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country.
View the report: Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast